@judgment
The White House is launching a new payment platform.
It focuses on popular GLP-1 medications.
The goal is to pressure major drug companies.
It also aims to bypass middlemen.
These intermediaries often keep U.S. drug prices high.
This move is a direct challenge to the current system.
0 reply
0 recast
0 reaction